Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $310

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $300 to $310.

Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $300 to $310.

Total
0
Shares
Related Posts